GC
AMED

Globeflex Capital’s Amedisys AMED Stock Holding History

Globeflex Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,485
Closed -$1.34M – 458
2021
Q2 		$1.34M Buy
5,485
+11
+0.2% +$2.89K 0.24% 142
2021
Q1 		$1.45M Hold
5,474
– – 0.26% 120
2020
Q4 		$1.61M Sell
5,474
-55
-1% -$14.1K 0.34% 79
2020
Q3 		$1.31M Sell
5,529
-616
-10% -$140K 0.35% 83
2020
Q2 		$1.22M Buy
6,145
+480
+8% +$89.5K 0.31% 92
2020
Q1 		$1.04M Sell
5,665
-1,257
-18% -$224K 0.32% 97
2019
Q4 		$1.16M Sell
6,922
-267
-4% -$39.7K 0.22% 151
2019
Q3 		$942K Hold
7,189
– – 0.21% 162
2019
Q2 		$873K Buy
+7,189
New +$853K 0.18% 187
2019
Q1 		– Sell
-19,293
Closed -$2.26M – 432
2018
Q4 		$2.26M Sell
19,293
-39
-0.2% -$4.6K 0.54% 29
2018
Q3 		$2.42M Buy
19,332
+32
+0.2% +$3.53K 0.47% 37
2018
Q2 		$1.65M Sell
19,300
-100
-0.5% -$7.34K 0.34% 84
2018
Q1 		$1.17M Hold
19,400
– – 0.25% 138
2017
Q4 		$1.02M Buy
+19,400
New +$1.02M 0.29% 130
2015
Q4 		– Sell
-14,100
Closed -$535K – 441
2015
Q3 		$535K Buy
+14,100
New +$595K 0.11% 279

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Globeflex Capital's AMED Position: Q3 2021 in Review

Globeflex Capital sold out of Amedisys (AMED) in Q3 2021, closing a stake of 5,485 shares — an estimated $1.34M sold.

Globeflex Capital first reported a position in AMED in Q3 2015 and held it in 15 quarters. The position peaked at $2.42M in Q3 2018. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Globeflex Capital reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Globeflex Capital sold 5,485 Amedisys shares in Q3 2021, an estimated $1.34M.
  • Globeflex Capital first reported a position in Amedisys in Q3 2015 and held it in 15 quarters.
  • Globeflex Capital's Amedisys position peaked at $2.42M in Q3 2018.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Globeflex Capital's 13F filing for Q3 2021, filed 12 Nov 2021.